Dementia and Alzheimer Disease

The NeurologyLive® dementia and Alzheimer disease clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to the care of patients with dementia and similar diseases, including Lewy body dementia, frontotemporal dementia, Alzheimer disease, and more.

Latest News

FDA AdComm Recommends Antiamyloid Therapy Donanemab as New Treatment for Alzheimer Disease
FDA AdComm Recommends Antiamyloid Therapy Donanemab as New Treatment for Alzheimer Disease

June 10th 2024

In a pivotal, large-scale, phase 3 trial, donanemab met its primary end point, demonstrating more pronounced effects in patients with early-stage Alzheimer disease who had low/medium tau status.

FDA Action Update, May 2024: Approvals, Designations, and Labeling Update
FDA Action Update, May 2024: Approvals, Designations, and Labeling Update

June 10th 2024

FDA Accepts Eisai’s sBLA for New IV Maintenance Dosing of Lecanemab
FDA Accepts Eisai’s sBLA for New IV Maintenance Dosing of Lecanemab

June 10th 2024

This Week on NeurologyLive® — June 10, 2024
This Week on NeurologyLive® — June 10, 2024

June 10th 2024

NeurologyLive® Brain Games: June 9, 2024
NeurologyLive® Brain Games: June 9, 2024

June 9th 2024

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, ...

September 15, 2024

Register Now!

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

October 16, 2024

Register Now!

Mastering MS: Translating Evidence into Optimal Management Plans

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

View More

Burst CME: Optimizing Therapy in Parkinson’s Disease

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders

View More

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

View More

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

View More

More News

© 2024 MJH Life Sciences

All rights reserved.